Blood Group B antigen Antibody (HEB-29) is a mouse monoclonal IgM antibody that detects Blood Group B Antigen of human origin by immunofluorescence (IF) and immunohistochemistry with paraffin-embedded sections (IHCP). Anti-Blood Group B antigen antibody (HEB-29) is available in non-conjugated form. Blood Group B antigen is a crucial component of the ABO blood group system, playing a significant role in transfusion medicine and organ transplantation. Blood Group B antigen is primarily located on the surface of erythrocytes and certain epithelial cells, formed by adding specific sugar residues to precursor molecules. Blood Group B antigen presence is vital for determining blood compatibility, as mismatched transfusions can lead to severe immune reactions. Blood Group B antigen expression can be modulated during malignant transformation, potentially influencing tumor immunology and patient outcomes. Understanding Blood Group B antigen distribution and function is essential for both clinical applications and research into immune response and disease progression mechanisms.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Blood Group B antigen Antibody (HEB-29) References:
- Development of H activity by human blood-group B substance treated with coffee bean alpha-galactosidase. | WATKINS, WM., et al. 1962. Nature. 195: 1204-6. PMID: 14005253
- Isolation of a B-specific disaccharide from human blood-group B substance. | PAINTER, TJ., et al. 1962. Nature. 193: 1042-4. PMID: 14483250
- Loss of blood-group-B antigen in chronic lymphatic leukaemia. | RICHARDS, AG. 1962. Lancet. 2: 178-9. PMID: 14491924
- Bifidobacterial α-galactosidase with unique carbohydrate-binding module specifically acts on blood group B antigen. | Wakinaka, T., et al. 2013. Glycobiology. 23: 232-40. PMID: 23089618
- Suppressed expression of blood group B antigen and blood group galactosyltransferase in a preleukemic subject. | Yoshida, A., et al. 1985. Blood. 66: 990-2. PMID: 3929862
- Immunochemical studies on blood groups. LII. Structures and activities of oligosaccharides produced by alkaline degradation of a blood group B substance previously subjected to partial hydrolysis by dilute hydrochloric acid. | Lundblad, A., et al. 1972. Arch Biochem Biophys. 148: 291-303. PMID: 4110197
- Normal blood group B antigen and B transferase activity in a patient with IgM autoanti-B agglutinin. | Lopez, M., et al. 1978. Vox Sang. 34: 18-21. PMID: 414449
- Expression of a blood group B antigen-related glycoepitope in human dorsal root ganglion cells. | Yamada, M., et al. 1994. J Neurol Sci. 126: 178-83. PMID: 7531759
- Sandwich capture enzyme immunoassay for water soluble blood group B substance in secretor saliva. | Yukawa, N., et al. 1995. J Immunoassay. 16: 247-61. PMID: 7593648
- A monoclonal IgM kappa from a blood group B individual with specificity for alpha-galactosyl epitopes on partially hydrolyzed blood group B substance. | Nickerson, KG., et al. 1993. Carbohydr Res. 243: 345-57. PMID: 7688662